ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)

Infectious Diseases Society of America

Enders, J. F. (1969) · The Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,305 · see citing works

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191 · see citing works

Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia

Cornely, O. A., Maertens, J. A., Winston, D. J., Perfect, J. R., Ullmann, A. J., Walsh, T. J., HELFGOTT, D. C., Hołowiecki, J., Stockelberg, D., Goh, Y. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,802 · see citing works

Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database

Kontoyiannis, D. P., Marr, K. A., Park, B. J., Alexander, B. D., Anaissie, E. J., Walsh, T. J., Ito, J., Andes, D. R., Baddley, J. W., Brown, J. M., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/651263 · Cited by 1,456 · see citing works

Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis

Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380 · see citing works

Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease

Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P. H., Langston, A. A., Tarantolo, S., Greinix, H., de Azevedo, W. M., Reddy, V. S., Boparai, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061098 · Cited by 1,339 · see citing works

Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia

Walsh, T. J., Finberg, R. W., Arndt, C., Hiemenz, J., Schwartz, C., Bodensteiner, D., Pappas, P., Seibel, N., Greenberg, R. N., Dummer, S., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401004 · Cited by 1,205 · see citing works

A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow Transplantation

Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B. C., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P. J., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,168 · see citing works

A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia

Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039 · see citing works

Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever

Walsh, T. J., Pappas, P., Winston, D. J., Lazarus, H. M., Petersen, F., Raffalli, J., Yanovich, S., Stiff, P., Greenberg, R., Donowitz, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejm200201243460403 · Cited by 979 · see citing works

Practice Guidelines for the Treatment of Candidiasis

Rex, J. H., Walsh, T. J., Sobel, J. D., Filler, S. G., Pappas, P. G., Dismukes, W. E., & Edwards, J. E. (2000) · Clinical Infectious Diseases · doi:10.1086/313749 · Cited by 927 · see citing works

Untitled work

(2006) · PubMed · Cited by 906 · see citing works

Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia

Walsh, T. J., Teppler, H., Donowitz, G. R., Maertens, J. A., Baden, L. R., Dmoszyńska, A., Cornely, O. A., Bourque, M. R., Lupinacci, R. J., Sable, C. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040446 · Cited by 905 · see citing works

Anidulafungin versus Fluconazole for Invasive Candidiasis

Reboli, A. C., Rotstein, C., Pappas, P. G., Chapman, S. W., Kett, D. H., Kumar, D., Betts, R., Wible, M., Goldstein, B. P., Schranz, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066906 · Cited by 894 · see citing works

Management of Fever in Patients with Cancer and Treatment-Induced Neutropenia

Wood, A. J. J., & Pizzo, P. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305063281808 · Cited by 847 · see citing works

Efficacy and Safety of Fluconazole Prophylaxis for Fungal Infections after Marrow Transplantation--A Prospective, Randomized, Double-Blind Study

Slavin, M. A., Osborne, B., Adams, R. H., Levenstein, M. J., Schoch, H. G., Feldman, A. R., Meyers, J. D., & Bowden, R. A. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1545 · Cited by 812 · see citing works

Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry

Neofytos, D., Horn, D., Anaissie, E., Steinbach, W., Olyaei, A., Fishman, J., Pfaller, M., Chang, C., Webster, K., & Marr, K. (2009) · Clinical Infectious Diseases · doi:10.1086/595846 · Cited by 801 · see citing works

Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials

Andes, D. R., Safdar, N., Baddley, J. W., Playford, G., Reboli, A. C., Rex, J. H., Sobel, J. D., Pappas, P. G., Kullberg, B. J., & for the Mycoses Study Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis021 · Cited by 793 · see citing works

Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins

Kuhn, D. M., George, T., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1773-1780.2002 · Cited by 765 · see citing works

Micafungin versus Fluconazole for Prophylaxis against Invasive Fungal Infections during Neutropenia in Patients Undergoing Hematopoietic Stem Cell Transplantation

van Burik, J. H., Ratanatharathorn, V., Stepan, D. E., Miller, C. B., Lipton, J. H., Vesole, D. H., Bunin, N., Wall, D. A., Hiemenz, J., Satoi, Y., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/422312 · Cited by 741 · see citing works

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

Kuse, E.-R., Chetchotisakd, P., da Cunha, C. A., Ruhnke, M., Barrios, C., Raghunadharao, D., Sekhon, J. S., Freire, A., Ramasubramanian, V., Demeyer, I., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60605-9 · Cited by 692 · see citing works

Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis

Pappas, P. G., Rotstein, C. M. F., Betts, R. F., Nucci, M., Talwar, D., De Waele, J. J., Vazquez, J. A., Dupont, B. F., Horn, D. L., Ostrosky-Zeichner, L., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/520980 · Cited by 638 · see citing works

Amphotericin B Lipid Complex for Invasive Fungal Infections: Analysis of Safety and Efficacy in 556 Cases

Walsh, T. J., Hiemenz, J. W., Seibel, N. L., Perfect, J. R., Horwith, G., Lee, L., Silber, J. L., DiNubile, M. J., Reboli, A. C., Bow, E. J., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/516353 · Cited by 623 · see citing works

Candidemia in Cancer Patients: A Prospective, Multicenter Surveillance Study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)

Viscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514731 · Cited by 601 · see citing works

Galactomannan and Computed Tomography-Based Preemptive Antifungal Therapy in Neutropenic Patients at High Risk for Invasive Fungal Infection: A Prospective Feasibility Study

Maertens, J. A., Theunissen, K., Verhoef, G. E. G., Verschakelen, J., Lagrou, K., Verbeken, E. K., Wilmer, A., Verhaegen, J., Boogaerts, M. A., & Eldere, J. V. (2005) · Clinical Infectious Diseases · doi:10.1086/496927 · Cited by 590 · see citing works

A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile Neutropenia

Wingard, J. R., White, M. H., Anaissie, E. J., Raffalli, J. T., Goodman, J., Arrieta, A. C., & L Amph/ABLC Collaborative Study Group (2000) · Clinical Infectious Diseases · doi:10.1086/317451 · Cited by 524 · see citing works

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

Kullberg, B., Sobel, J., Ruhnke, M., Pappas, P., Viscoli, C., Rex, J., Cleary, J., Rubinstein, E., Church, L., Brown, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67490-9 · Cited by 521 · see citing works

Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial

Marr, K. A., Seidel, K. D., Slavin, M. A., Bowden, R. A., Schoch, H. G., Flowers, M. E. D., Corey, L., & Boeckh, M. (2000) · Blood · doi:10.1182/blood.v96.6.2055 · Cited by 510 · see citing works

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects

Rex, J. H., Pappas, P. G., Karchmer, A. W., Sobel, J., Edwards, J. E., Hadley, S., Brass, C., Vazquez, J. A., Chapman, S. W., Horowitz, H. W., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374850 · Cited by 495 · see citing works

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

Wingard, J. R., Carter, S. L., Walsh, T. J., Kurtzberg, J., Small, T. N., Baden, L. R., Gersten, I. D., Mendizabal, A. M., Leather, H. L., Confer, D. L., et al. (2010) · Blood · doi:10.1182/blood-2010-02-268151 · Cited by 478 · see citing works

Mortality and Costs of Acute Renal Failure Associated with Amphotericin B Therapy

Bates, D. W., Su, L., Yu, D. T., Chertow, G. M., Seger, D. L., Gomes, D. R. J., Dasbach, E. J., & Platt, R. (2001) · Clinical Infectious Diseases · doi:10.1086/319211 · Cited by 451 · see citing works

Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants

Marr, K. A., Crippa, F., Leisenring, W. M., Hoyle, M., Boeckh, M., Balajee, S. A., Nichols, W. G., Musher, B., & Corey, L. (2003) · Blood · doi:10.1182/blood-2003-08-2644 · Cited by 440 · see citing works

A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients

Prentice, H. G., Hann, I. M., Herbrecht, R., Aoun, M., Kvaløy, S., Catovsky, D., Pinkerton, R., Schey, S., Jacobs, F., Oakhill, A., et al. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.2473063.x · Cited by 437 · see citing works

Empirical versus Preemptive Antifungal Therapy for High‐Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial

Cordonnier, C., Pautas, C., Maury, S., Vekhoff, A., Farhat, H., Suárez, F., Dhédin, N., Isnard, F., Adès, L., Kuhnowski, F., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/597395 · Cited by 389 · see citing works

Intravenous and Oral Itraconazole versus Intravenous and Oral Fluconazole for Long-Term Antifungal Prophylaxis in Allogeneic Hematopoietic Stem-Cell Transplant Recipients: A Multicenter, Randomized Trial

Winston, D. J., Maziarz, R. T., Chandrasekar, P. H., Lazarus, H. M., Goldman, M., Blumer, J. L., Leitz, G. J., & Territo, M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-9-200305060-00006 · Cited by 388 · see citing works

Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients

Lortholary, O., Desnos-Ollivier, M., Sitbon, K., Fontanet, A., Bretagne, S., & Dromer, F. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01128-10 · Cited by 362 · see citing works

Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005–2007)

Lortholary, O., Gangneux, J.-P., Sitbon, K., Lebeau, B., de Monbrison, F., Le Strat, Y., Coignard, B., Dromer, F., & Bretagne, S. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03548.x · Cited by 331 · see citing works

Intravenous and Oral Itraconazole versus Intravenous Amphotericin B Deoxycholate as Empirical Antifungal Therapy for Persistent Fever in Neutropenic Patients with Cancer Who Are Receiving Broad-Spectrum Antibacterial Therapy: A Randomized, Controlled Trial

Boogaerts, M., Winston, D. J., Bow, E. J., Garber, G., Reboli, A. C., Schwarer, A. P., Novitzky, N., Boehme, A., Chwetzoff, E., De Beule, K., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00010 · Cited by 321 · see citing works

A Randomized Double‐Blind Study of Caspofungin versus Amphotericin for the Treatment of Candidal Esophagitis

Villanueva, A., Arathoon, E. G., Gotuzzo, E., Berman, R. S., DiNubile, M. J., & Sable, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/323401 · Cited by 308 · see citing works

A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis.

Pachl, J., Svoboda, P., Jacobs, F., Vandewoude, K., van der Hoven, B., Spronk, P., Masterson, G., Malbrain, M., Aoun, M., Garbino, J., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/503428 · Cited by 307 · see citing works

Factors associated with mortality in transplant patients with invasive aspergillosis

Baddley, J. W., Andes, D. R., Marr, K. A., Kontoyiannis, D. P., Alexander, B. D., Kauffman, C. A., Oster, R. A., Anaissie, E. J., Walsh, T. J., Schuster, M. G., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/652768 · Cited by 303 · see citing works

Randomized, Double‐Blind Clinical Trial of Amphotericin B Colloidal Dispersion vs. Amphotericin B in the Empirical Treatment of Fever and Neutropenia

White, M. H., Bowden, R. A., Sandler, E. S., Graham, M. L., Noskin, G. A., Wingard, J. R., Goldman, M., van Burik, J., McCabe, A., Lin, J. S., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/514672 · Cited by 303 · see citing works

-Glucan Antigenemia Assay for the Diagnosis of Invasive Fungal Infections in Patients With Hematological Malignancies: A Systematic Review and Meta-Analysis of Cohort Studies From the Third European Conference on Infections in Leukemia (ECIL-3)

Lamoth, F., Cruciani, M., Mengoli, C., Castagnola, E., Lortholary, O., Richardson, M. D., Marchetti, O., & (ECIL-3), O. B. O. T. T. E. C. O. I. I. L. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir897 · Cited by 296 · see citing works

A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis

Villanueva, A., Gotuzzo, E., Arathoon, E., Noriega, L. M., Kartsonis, N. A., Lupinacci, R. J., Smietana, J. M., DiNubile, M. J., & Sable, C. A. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01191-9 · Cited by 290 · see citing works

Management of Invasive Candidal Infections: Results of a Prospective, Randomized, Multicenter Study of Fluconazole Versus Amphotericin B and Review of the Literature

Anaissie, E. J., Darouiche, R. O., Abi-Said, D., Uzun, Ö., Mera, J., Gentry, L. O., Williams, T. M., Kontoyiannis, D. P., Karl, C., & Bodey, G. P. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.5.964 · Cited by 276 · see citing works

Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in intensive care unit (ICU) and non-ICU settings in the SENTRY antimicrobial surveillance program (2008–2009)

Pfaller, M. A., Messer, S. A., Moet, G. J., Jones, R. N., & Castanheira, M. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.02.016 · Cited by 274 · see citing works

Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001‐2007): Stable incidence but changing epidemiology of a still frequently lethal infection

Sipsas, N. V., Lewis, R. E., Tarrand, J., Hachem, R., Rolston, K. V., Raad, I. I., & Kontoyiannis, D. P. (2009) · Cancer · doi:10.1002/cncr.24507 · Cited by 269 · see citing works

Randomized, Double-Blind, Multicenter Study of Caspofungin versus Amphotericin B for Treatment of Oropharyngeal and Esophageal Candidiases

Arathoon, E. G., Gotuzzo, E., Noriega, L. M., Berman, R. S., DiNubile, M. J., & Sable, C. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.451-457.2002 · Cited by 254 · see citing works

Treatment of invasive fungal infections in cancer patients—updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

Mousset, S., Buchheidt, D., Heinz, W., Ruhnke, M., Cornely, O. A., Egerer, G., Krüger, W., Link, H., Neumann, S., Ostermann, H., et al. (2013) · Annals of Hematology · doi:10.1007/s00277-013-1867-1 · Cited by 253 · see citing works

Itraconazole Oral Solution as Prophylaxis for Fungal Infections in Neutropenic Patients with Hematologic Malignancies: A Randomized, Placebo‐Controlled, Double‐Blind, Multicenter Trial

Menichetti, F., Del Favero, A., Martino, P., Bucaneve, G., Micozzi, A., Girmenia, C., Barbabietola, G., Pagano, L., Leoni, P., Specchia, G., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/515129 · Cited by 244 · see citing works

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem‐cell transplantation

Marks, D. I., Pagliuca, A., Kibbler, C. C., Glasmacher, A. G., Heußel, C. P., Kantecki, M., Miller, P. J. S., Ribaud, P., Schlamm, H. T., Solano, C., et al. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08838.x · Cited by 239 · see citing works

Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials

Nucci, M., Anaissie, E., Betts, R. F., Dupont, B. F., Wu, C., Buell, D. N., Kovanda, L., & Lortholary, O. (2010) · Clinical Infectious Diseases · doi:10.1086/653935 · Cited by 228 · see citing works

Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction

Estcourt, L. J., Stanworth, S. J., Doree, C. J., Blanco, P., Hopewell, S., Trivella, M., & Massey, E. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005341.pub3 · Cited by 214 · see citing works

Micafungin Versus Liposomal Amphotericin B for Pediatric Patients With Invasive Candidiasis

Queiroz‐Telles, F., Berezin, E. N., Leverger, G., Freire, A., van der Vyver, A., Chotpitayasunondh, T., Konja, J., Diekmann-Berndt, H., Koblinger, S., Groll, A. H., et al. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31817275e6 · Cited by 210 · see citing works

A Randomized, Double-Blind, Parallel-Group, Dose-Response Study of Micafungin Compared with Fluconazole for the Treatment of Esophageal Candidiasis in HIV-Positive Patients

Wet, N. T. E. D., Llanos‐Cuentas, A., Suleiman, J. M. A. H., Baraldi, E., Krantz, E., Negra, M. D., & Diekmann-Berndt, H. (2004) · Clinical Infectious Diseases · doi:10.1086/423377 · Cited by 203 · see citing works

A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies

Morgenstern, G. R., Prentice, A. G., Prentice, H. G., Ropner, J. E., Schey, S., & Warnock, D. W. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01465.x · Cited by 200 · see citing works

A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer

Winston, D. J., Hathorn, J. W., Schuster, M. G., Schiller, G. J., & Territo, M. C. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00457-x · Cited by 189 · see citing works

Fluconazole versus Amphotericin B in the treatment of Hematogenous Candidiasis: A matched cohort study

Anaissie, E. J., Vartivarian, S. E., Abi-Said, D., Uzun, Ö., Pinczowski, H., Kontoyiannis, D. P., Khoury, P. N., Papadakis, K., Gardner, A., RAAD, I. I., et al. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)80072-6 · Cited by 186 · see citing works

Diagnostic Issues, Clinical Characteristics, and Outcomes for Patients with Fungemia

Arendrup, M. C., Sulim, S., Holm, A., Nielsen, L. B., Nielsen, S. D., Knudsen, J. D., Drenck, N. E., Christensen, J. J., & Johansen, H. K. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00179-11 · Cited by 177 · see citing works

A Multicenter Randomized Trial Evaluating Posaconazole versus Fluconazole for the Treatment of Oropharyngeal Candidiasis in Subjects with HIV/AIDS

Vázquez, J. A., Skiest, D. J., Nieto, L., Northland, R., Sanne, I., Gogate, J. P., Greaves, W. L., & ISAACS, R. E. (2006) · Clinical Infectious Diseases · doi:10.1086/501457 · Cited by 171 · see citing works

Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death

Slavin, M. A., Sorrell, T. C., Marriott, D., Thursky, K., Nguyen, Q. A., Ellis, D. H., Morrissey, C. O., Chen, S. C.-A., & on behalf of the Australian Candidemia Study, A. S. F. I. D. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq053 · Cited by 163 · see citing works

Posaconazole for the Treatment of Azole-Refractory Oropharyngeal and Esophageal Candidiasis in Subjects with HIV Infection

Skiest, D. J., Vazquez, J. A., Anstead, G. M., Graybill, J. R., Reynes, J., Ward, D., Hare, R., Boparai, N., & Isaacs, R. (2007) · Clinical Infectious Diseases · doi:10.1086/511039 · Cited by 162 · see citing works

Adjuvant Corticosteroid Therapy for Chronic Disseminated Candidiasis

Legrand, F., Lecuit, M., Dupont, B., Bellaton, E., Huerre, M., Rohrlich, P.-S., & Lortholary, O. (2008) · Clinical Infectious Diseases · doi:10.1086/527390 · Cited by 157 · see citing works

Evaluation of Aspergillus PCR Protocols for Testing Serum Specimens

White, P. L., Mengoli, C., Bretagne, S., Cuenca‐Estrella, M., Finnström, N., Klingspor, L., Melchers, W. J. G., McCulloch, E., Barnes, R. A., Donnelly, J. P., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05316-11 · Cited by 156 · see citing works

Itraconazole Oral Solution for Primary Prophylaxis of Fungal Infections in Patients with Hematological Malignancy and Profound Neutropenia: a Randomized, Double-Blind, Double-Placebo, Multicenter Trial Comparing Itraconazole and Amphotericin B

Harousseau, J., Dekker, A. W., Stamatoullas, A., Fassas, Α., Linkesch, W., Gouveia, J., Bock, R. D., Rovira, M., Seifert, W., Joosen, H., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.7.1887-1893.2000 · Cited by 154 · see citing works

A Multicenter, Open-Label Clinical Study of Micafungin (FK463) in the Treatment of Deep-seated Mycosis in Japan

Kohno, S., Masaoka, T., Yamaguchi, H., Mori, T., Urabe, A., Ito, A., Niki, Y., & IKEMOTO, H. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410020406 · Cited by 152 · see citing works

ESCMID guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases

Ullmann, A. J., Cornely, O. A., DonneNy, J. P., Akova, M., Arendrup, M. C., Arıkan-Akdağlı, S., Bassetti, M., Billé, J., Calandra, T., Castagnola, E., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12037 · Cited by 150 · see citing works

A Randomized, Double-Blind, Multicenter Study of Caspofungin Versus Liposomal Amphotericin B for Empiric Antifungal Therapy in Pediatric Patients With Persistent Fever and Neutropenia

Maertens, J. A., Madero, L., Reilly, A. F., Lehrnbecher, T., Groll, A. H., Jafri, H. S., Green, M., Nania, J. J., Bourque, M. R., Wise, B. A., et al. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181da2171 · Cited by 137 · see citing works

Fluconazole Compared with Ketoconazole for the Treatment of Candida Esophagitis in AIDS: A Randomized Trial

Laine, L., Dretler, R. H., Conteas, C. N., Tuazon, C., Koster, F. M., Sattler, F., Squires, K., & Islam, M. Z. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-8-655 · Cited by 131 · see citing works

<i>Candida</i> spp. with Acquired Echinocandin Resistance, France, 2004–20101

Dannaoui, E., Desnos-Ollivier, M., Garcia-Hermoso, D., Grenouillet, F., Cassaing, S., Baixench, M.-T., Bretagne, S., Dromer, F., Lortholary, O., & the French Mycoses Study Group (2012) · Emerging infectious diseases · doi:10.3201/eid1801.110556 · Cited by 130 · see citing works

Voriconazole Salvage Treatment of Invasive Candidiasis

Ostrosky‐Zeichner, L., Lashof, A. M. L. O., Kullberg, B. J., & Rex, J. H. (2003) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-1014-3 · Cited by 125 · see citing works

Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial

Viscoli, C., Castagnola, E., Van Lint, M. T., Moroni, C., Garaventa, A., Rossi, M. R., Fanci, R., Menichetti, F., Caselli, D., Giacchino, M., et al. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00619-2 · Cited by 122 · see citing works

Treatment of invasive fungal infections in cancer patients—Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

Böhme, A., Ruhnke, M., Buchheidt, D., Cornely, O. A., Einsele, H., Enzensberger, R., Hebart, H. F., Heinz, W., Junghanß, C., Karthaus, M., et al. (2008) · Annals of Hematology · doi:10.1007/s00277-008-0622-5 · Cited by 122 · see citing works

Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial

Penack, O., Schwartz, S., Martus, P., Reinwald, M., Schmidt‐Hieber, M., Thiel, E., & Blau, I. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl128 · Cited by 116 · see citing works

Prospective Study of Amphotericin B Formulations in Immunocompromised Patients in 4 European Countries

Ullmann, A. J., Sanz, M. Á., Tramarin, A., Barnes, R. A., Wu, W., Gerlach, B., Krobot, K. J., Gerth, W. C., & on behalf of the Longitudinal Evaluation of Antifungal Drugs (LEAD I) Investigators (2006) · Clinical Infectious Diseases · doi:10.1086/505969 · Cited by 115 · see citing works

A Double-Blind, Randomized, Placebo-Controlled Trial of Itraconazole Capsules as Antifungal Prophylaxis for Neutropenic Patients

Nucci, M., Biasoli, I., Akiti, T., Silveira, F., Solza, C., Barreiros, G., Spector, N., Derossi, A., & Pulcheri, W. (2000) · Clinical Infectious Diseases · doi:10.1086/313654 · Cited by 114 · see citing works

Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia

Philpott‐Howard, J., Wade, J. J., Mufti, G. J., Brammer, K. W., & Ehniniger, G. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/31.6.973 · Cited by 113 · see citing works

Randomized Trial of Itraconazole Oral Solution for Oropharyngeal Candidiasis in HIV/AIDS Patients

Graybill, J. R., Vázquez, J. A., Darouiche, R. O., Morhart, R. E., Greenspan, D., Tuazon, C. U., Wheat, L. J., CAREY, J. J., Leviton, I. M., Hewitt, R. G., et al. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00307-0 · Cited by 108 · see citing works

Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia

Gotzsche, P. C., & Johansen, H. (1997) · BMJ · doi:10.1136/bmj.314.7089.1238 · Cited by 106 · see citing works

A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemicCandida infections in intensive care patients

Abele‐Horn, M., Köpp, A., Sternberg, U., Ohly, A., Nagengast, O., Dauber, A., Russwurm, W., Büchinger, W., & Emmerling, P. (1996) · Infection · doi:10.1007/bf01713042 · Cited by 105 · see citing works

An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia

Glasmacher, A. G., Cornely, O. A., Ullmann, A. J., Wedding, U., Bodenstein, H., Wandt, H., Boewer, C., Pasold, R., Wolf, H., Hänel, M., et al. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki440 · Cited by 104 · see citing works

Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived) in cancer patients with fever and neutropenia

Anaissie, E. J., Vartivarian, S. E., Bodey, G. P., Legrand, C., Kantarjian, H. M., Abi-Said, D., Karl, C. L., & Vadhan‐Raj, S. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)90006-6 · Cited by 95 · see citing works

Oropharyngeal Candidiasis in Patients with AIDS: Randomized Comparison of Fluconazole Versus Nystatin Oral Suspensions

Pons, V., Greenspan, D., Lozada-Nur, F. I., McPhail, L., Gallant, J. E., Tunkel, A. R., Johnson, C. C., McCarty, J. M., Panzer, H., Levenstein, M., et al. (1997) · Clinical Infectious Diseases · doi:10.1086/513664 · Cited by 95 · see citing works

Clinically Driven Diagnostic Antifungal Approach in Neutropenic Patients: A Prospective Feasibility Study

Girmenia, C., Micozzi, A., Gentile, G., Santilli, S., Arleo, E., Cardarelli, L., Capria, S., Minotti, C., Cartoni, C., Brocchieri, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.8032 · Cited by 92 · see citing works

Hepatosplenic Yeast Infection in Patients with Acute Leukemia: A Diagnostic Problem

Anttila, V., Ruutu, P., Bondestam, S., Jansson, S. ‐., Nordling, S., Färkkilä, M. A., Sivonen, K., Castrén, M. K., & Ruutu, T. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.6.979 · Cited by 88 · see citing works

Chronic disseminated candidiasis in patients with hematologic malignancies. Clinical features and outcome of 29 episodes.

Pagano, L., Mele, L., Fianchi, L., Melillo, L. M. A., Martino, B., D’Antonio, D., Tosti, M. E., Posteraro, B., Sanguinetti, M., Trapè, G., et al. (2002) · PubMed · Cited by 87 · see citing works

Emergence ofCandida krusei infections after therapy of oropharyngeal candidiasis with fluconazole

Akova, M., Akalın, H., Uzun, Ö., & Gür, D. (1991) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01967286 · Cited by 86 · see citing works

Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections

Sachs, U. J., Reiter, A., Walter, T., Bein, G., & Woessmann, W. (2006) · Transfusion · doi:10.1111/j.1537-2995.2006.00996.x · Cited by 85 · see citing works

Detection of acute and treated lesions of hepatosplenic candidiasis: Conparison of dynamic contrast‐enhanced CT and MR Imaging

Semelka, R. C., Shoenut, J. P., Greenberg, H. M., & Bow, E. J. (1992) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880020315 · Cited by 81 · see citing works

Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection

Vazquez, J. (2010) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s6660 · Cited by 81 · see citing works

Fluconazole versus itraconazole for candida esophagitis in acquired immunodeficiency syndrome. Candida Esophagitis

Barbaro, G., Barbarini, G., Calderon, W., Grisorio, B., Alcini, P., & Di Lorenzo, G. (1996) · Gastroenterology · doi:10.1053/gast.1996.v111.pm8898629 · Cited by 78 · see citing works

Efficacy of Caspofungin in the Treatment of Esophageal Candidiasis Resistant to Fluconazole

Kartsonis, N., DiNubile, M. J., Bartizal, K., Hicks, P. S., Ryan, D., & Sable, C. A. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200210010-00009 · Cited by 77 · see citing works

Candida tropicalis fungaemia: incidence, risk factors and mortality in a general hospital

Muñóz, P., Giannella, M., Fanciulli, C., Guinea, J., Valerio, M., Rojas, L., Rodríguez‐Créixems, M., & Bouza, E. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03338.x · Cited by 76 · see citing works

Antifungal use influences Candida species distribution and susceptibility in the intensive care unit

Fournier, P., Schwebel, C., Maubon, D., Vesin, A., Lebeau, B., Foroni, L., Hamidfar-Roy, R., Cornet, M., Timsit, J., & Pelloux, H. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr394 · Cited by 76 · see citing works

Caspofungin as Primary Antifungal Prophylaxis in Stem Cell Transplant Recipients

Chou, L. S., Lewis, R. E., Ippoliti, C. M., Champlin, R. E., & Kontoyiannis, D. P. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.12.1644 · Cited by 75 · see citing works

Prevention of fungal infections in the immunocompromised host.

Mahfouz, T. H., & Anaissie, E. J. (2003) · PubMed · Cited by 74 · see citing works

Recombinant interferon γ1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions

Safdar, A., Rodriguez, G. H., Lichtiger, B., Dickey, B. F., Kontoyiannis, D. P., Freireich, E. J., Shpall, E. J., RAAD, I. I., Kantarjian, H. M., & Champlin, R. E. (2006) · Cancer · doi:10.1002/cncr.21929 · Cited by 73 · see citing works

Epidemiology ofCandidablood stream infections in patients with hematological malignancies or solid tumors

Zirkel, J., Klinker, H., Kuhn, A., Abele‐Horn, M., Tappe, D., Turnwald, D., Einsele, H., & Heinz, W. (2012) · Medical Mycology · doi:10.3109/13693786.2011.587211 · Cited by 71 · see citing works

Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME Study

Cordonnier, C., Mohty, M., Faucher, C., Pautas, C., Robin, M., Vey, N., Monchecourt, F., Mahi, L., & Ribaud, P. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.10.001 · Cited by 70 · see citing works

Immunomodulation with interferon‐gamma and colony‐stimulating factors for refractory fungal infections in patients with leukemia

Dignani, M. C., Rex, J. H., Chan, K., Dow, G., Magalhaes-Silverman, M. D., Maddox, A., Walsh, T. J., & Anaissie, E. J. (2005) · Cancer · doi:10.1002/cncr.21142 · Cited by 69 · see citing works

Canadian Clinical Practice Guidelines for Invasive Candidiasis in Adults

Bow, E. J., Evans, G. A., Fuller, J., Laverdière, M., Rotstein, C., Rennie, R. P., Shafran, S. D., Sheppard, D. C., Carle, S., Phillips, P., et al. (2010) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2010/357076 · Cited by 68 · see citing works

A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients

Oren, I., Rowe, J. M., Sprecher, H., Tamir, A., Benyamini, N., Akria, L., Gorelik, A., Dally, N., Zuckerman, T., Haddad, N., et al. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705418 · Cited by 67 · see citing works

Candidemia in cancer patients: Impact of early removal of non-tunneled central venous catheters on outcome

Liu, C. Y., Huang, L. J., Wang, W. S., Chen, T. L., Yen, C. C., Yang, M. H., Hsiao, L. T., Liu, C. Y., Chen, P. M., & Chiou, T. J. (2009) · Journal of Infection · doi:10.1016/j.jinf.2008.12.008 · Cited by 67 · see citing works

Nystatin prophylaxis and treatment in severely immunodepressed patients

Gøtzsche, P. C., & Johansen, H. K. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002033.pub2 · Cited by 66 · see citing works

Clinical efficacy of granulocyte transfusion therapy in patients with neutropenia-related infections

Lee, J.-J., Chung, I.-J., Park, M.-R., Kook, H., Hwang, T., Ryang, D., & Kim, H.-J. (2001) · Leukemia · doi:10.1038/sj.leu.2402007 · Cited by 65 · see citing works

The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients

Chandrasekar, P. H., & Gatny, C. M. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.2.309 · Cited by 62 · see citing works

Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: A retrospective, observational, sequential cohort analysis

Kubiak, D. W., Porter, J., McDonnell, A., Delgado-Flores, J. O., Mui, E., Baden, L. R., & Marty, F. M. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.04.005 · Cited by 62 · see citing works

Beta- d -Glucan Detection as a Diagnostic Test for Invasive Aspergillosis in Immunocompromised Critically Ill Patients with Symptoms of Respiratory Infection: an Autopsy-Based Study

Vlieger, G. D., Lagrou, K., Maertens, J. A., Verbeken, E. K., Meersseman, W., & Wijngaerden, E. V. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00879-11 · Cited by 62 · see citing works

Second-line therapy with caspofungin for mucosal or invasive candidiasis: results from the caspofungin compassionate-use study

Kartsonis, N. A. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh179 · Cited by 61 · see citing works

A prospective cohort study evaluating the prognostic impact of clinical characteristics and comorbid conditions of hospitalized adult and pediatric cancer patients with candidemia

Velasco, E., & Bigni, R. (2008) · European Journal of Clinical Microbiology &amp; Infectious Diseases · doi:10.1007/s10096-008-0546-y · Cited by 59 · see citing works

Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B

Dupont, B., Lortholary, O., Ostrosky‐Zeichner, L., Stucker, F., & Yeldandi, V. V. (2009) · Critical Care · doi:10.1186/cc8117 · Cited by 58 · see citing works

Treatment of Candida Infections with Amphotericin B Lipid Complex

Ito, J. I., & Hooshmand-Rad, R. (2005) · Clinical Infectious Diseases · doi:10.1086/429330 · Cited by 58 · see citing works

G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis

Grigull, L., Pulver, N., Goudeva, L., Sykora, K., Linderkamp, C., Beilken, A., Seidemann, K., Schmid, H., Welte, K., & Heuft, H. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0041-x · Cited by 57 · see citing works

Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients

Boogaerts, M. A. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.1.97 · Cited by 57 · see citing works

Breakthrough Candidemia in Patients with Cancer Differs from De Novo Candidemia in Host Factors andCandidaSpecies But Not Intensity

Kontoyiannis, D. P., Reddy, B. T., Hanna, H. A., Bodey, G. P., Tarrand, J. T., & RAAD, I. I. (2002) · Infection Control and Hospital Epidemiology · doi:10.1086/502104 · Cited by 55 · see citing works

Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients

Murray, P. A., Koletar, S. L., Mallegol, I., Wu, J., & Moskovitz, B. L. (1997) · Clinical Therapeutics · doi:10.1016/s0149-2918(97)80131-2 · Cited by 52 · see citing works

Hepatosplenic fungal infection in patients with acute leukemia in Taiwan: incidence, treatment, and prognosis

Chen, C., Chen, Y., Tang, J., Yao, M., Huang, S., Tsai, W., Chen, Y., Shen, M., Wang, C., & Tien, H. (2003) · Annals of Hematology · doi:10.1007/s00277-002-0588-7 · Cited by 50 · see citing works

Immune reconstitution syndrome and fungal infections

Gupta, A. O., & Singh, N. (2011) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32834ab20a · Cited by 50 · see citing works

Amphotericin B Colloidal Dispersion for Treatment of Candidemia in Immunocompromised Patients

Noskin, G. A., Pietrelli, L. A., Coffey, G., Gurwith, M., & Liang, L.-J. F. (1998) · Clinical Infectious Diseases · doi:10.1086/516314 · Cited by 49 · see citing works

Prior Caspofungin Exposure in Patients with Hematological Malignancies Is a Risk Factor for Subsequent Fungemia Due to Decreased Susceptibility in Candida spp.: a Case-Control Study in Paris, France

Blanchard, É., Lortholary, O., Sitbon, K., Desnos‐Ollivier, M., Dromer, F., Guillemot, D., & the French Mycosis Study Group (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00690-11 · Cited by 47 · see citing works

Randomized, Comparative, Double-Blind, Double-Dummy, Multicenter Trial of Miconazole Buccal Tablet and Clotrimazole Troches for the Treatment of Oropharyngeal Candidiasis: Study of Miconazole Lauriad®Efficacy and Safety (SMiLES)

Vazquez, J. A., Patton, L. L., Epstein, J. B., Ramlachan, P., Mitha, I. H., Noveljic, Z., Fourie, J., Conway, B., Lalla, R. V., Barasch, A., et al. (2010) · HIV Clinical Trials · doi:10.1310/hct1104-186 · Cited by 46 · see citing works

A Phase 2, Open-Label Study of the Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis

Vázquez, J. A., Schranz, J., Clark, K., Goldstein, B. P., Reboli, A. C., & Fichtenbaum, C. J. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31817af47a · Cited by 45 · see citing works

Granulocyte transfusions for neutropenic patients with life‐threatening infections: a single centre experience in 47 patients, who received 348 granulocyte transfusions

Ofran, Y., Avivi, I. M., Oliven, A., Oren, I., Zuckerman, T., Bonstein, L., Rowe, J. M., & Dann, E. J. (2007) · Vox Sanguinis · doi:10.1111/j.1423-0410.2007.00971.x · Cited by 44 · see citing works

Efficacy and safety of micafungin, an echinocandin antifungal agent, on invasive fungal infections in patients with hematological disorders

Tamura, K., Urabe, A., Yoshida, M., Kanamaru, A., Kodera, Y., Okamoto, S., Maesaki, S., & Masaoka, T. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190802635500 · Cited by 43 · see citing works

Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction

Massey, E., Paulus, U., Doree, C. J., & Stanworth, S. J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005341.pub2 · Cited by 42 · see citing works

Itraconazol‐Suspension in der Behandlung HIV‐infizierter Patienten mit Fluconazol‐resistenter oropharyngealer <i>Candida</i>‐Infektion und Soorösophagitis

Eichel, M., Just‐Nübling, G., Helm, E. B., & Stille, W. (1996) · Mycoses · doi:10.1111/j.1439-0507.1996.tb00514.x · Cited by 41 · see citing works

An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis

Lashof, A. M. L. O., Bock, R. D., Herbrecht, R., Pauw, B. E. D., Krcmery, V., Aoun, M., Akova, M., Cohen, J., Šiffnerová, H., Egyed, M., et al. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.03.003 · Cited by 40 · see citing works

Nystatin prophylaxis and treatment in severely immunodepressed patients

Gøtzsche, P. C., & Johansen, H. K. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002033 · Cited by 39 · see citing works

Diagnosis and Monitoring Response to Treatment of Hepatosplenic Candidiasis in Patients with Acute Leukemia Using Magnetic Resonance Imaging

Sallah, S., Semelka, R. C., Kelekis, N., Worawattanakul, S., & Sallah, W. (1998) · Acta Haematologica · doi:10.1159/000040869 · Cited by 38 · see citing works

Safety and Efficacy of Itraconazole Compared to Amphotericin B as Empirical Antifungal Therapy for Neutropenic Fever in Patients with Haematological Malignancy*

Schuler, U. S., Bammer, S., Aulitzky, W. E., Binder, C. R., Böhme, A., Egerer, G., Sandherr, M., Schwerdtfeger, R., Silling, G., Wandt, H., et al. (2007) · Oncology Research and Treatment · doi:10.1159/000100055 · Cited by 35 · see citing works

Treatment of invasive fungal infections with amphotericin B colloidal dispersion in bone marrow transplant recipients

Noskin, G. A., Pietrelli, L. A., Gurwith, M., & Bowden, R. A. (1999) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1701630 · Cited by 33 · see citing works

Five-years surveillance of invasive aspergillosis in a university hospital

Graf, K., Khani, S. M., Ott, E., Mattner, F., Gastmeier, P., Sohr, D., Ziesing, S., & Chaberny, I. F. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-163 · Cited by 32 · see citing works

Development of a 96-well catheter-based microdilution method to test antifungal susceptibility of Candida biofilms

Nweze, E. I., Ghannoum, A., Chandra, J., Ghannoum, M. A., & Mukherjee, P. K. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr429 · Cited by 31 · see citing works

Pappas et al. (2007; 45:883–93)

(2008) · Clinical Infectious Diseases · doi:10.1086/590000 · Cited by 31 · see citing works

Fluconazole Compared with Itraconazole in the Treatment of Esophageal Candidiasis in AIDS Patients: A Double-blind, Randomized, Controlled Clinical Study

Bárbaro, G., Barbarini, G., & Lorenzo, G. D. (1995) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549509047076 · Cited by 30 · see citing works

Echinocandin Susceptibility Testing of Candida Isolates Collected during a 1-Year Period in Sweden

Elings, M. A., Botero-Kleiven, S., Hare, R. K., & Arendrup, M. C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00201-11 · Cited by 30 · see citing works

Efficacy of Fluconazole in the Treatment of Upper Gastrointestinal Candidiasis in Neutropenic Patients with Cancer: Factors Influencing the Outcome

Akova, M., Akalın, H., Uzun, Ö., Hayran, M., Tekuzman, G., Kansu, E., Asian, S., & TELATAR, H. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.3.298 · Cited by 29 · see citing works

Early detection of chronic disseminated Candida infection in leukemia patients with febrile neutropenia: value of computer-assisted serial ultrasound documentation

Karthaus, M., Huebner, G., Elser, C., Geißler, R. G., Heil, G., & Ganser, A. (1998) · Annals of Hematology · doi:10.1007/s002770050409 · Cited by 29 · see citing works

Fluconazole vs. Flucytosine in the Treatment of Esophageal Candidiasis in AIDS Patients: A Double-Blind, Placebo-Controlled Study

Barbaro, G., Barbarini, G., & Di Lorenzo, G. (1995) · Endoscopy · doi:10.1055/s-2007-1005717 · Cited by 27 · see citing works

Correlation of In Vitro Fluconazole Susceptibility with Clinical Outcome for Severely Ill Patients with Oropharyngeal Candidiasis

Arıkan, S., Akova, M., Hayran, M., Özdemir, O., Erman, M., Gür, D., & Ünal, S. (1998) · Clinical Infectious Diseases · doi:10.1086/513927 · Cited by 27 · see citing works

Candida spp. with Acquired Echinocandin Resistance, France,

Dannaoui, É., Desnos‐Ollivier, M., Garcia‐Hermoso, D., Grenouillet, F., Cassaing, S., Baixench, M.-T., Bretagne, S., Dromer, F., & Lortholary, O. (2012) · Cited by 27 · see citing works

Adjuvant Corticosteroid Therapy in 2 Children With Hepatosplenic Candidiasis-related IRIS

Saint-Faust, M., Boyer, C., Gari-Toussaint, M., Deville, A., Poirée, M., Weintraub, M., & Sirvent, N. (2009) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3181b795ec · Cited by 26 · see citing works

Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA)

Ito, J. I., Chandrasekar, P. H., & Hooshmand-Rad, R. (2005) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705143 · Cited by 25 · see citing works

Antifungal prophylaxis with micafungin in neutropenic patients with hematological malignancies

Hirata, Y., Yokote, T., Kobayashi, K., Nakayama, S., Oka, S., Miyoshi, T., Akioka, T., Hiraoka, N., Iwaki, K., Takayama, A., et al. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428191003682726 · Cited by 25 · see citing works

Infection: the new problems.

Rubin, R. H., & TOLKOFF-RUBIN, N. E. (1989) · PubMed · Cited by 25 · see citing works

Optimization of the Dosage of Flucytosine in Combination with Amphotericin B for Disseminated Candidiasis: a Pharmacodynamic Rationale for Reduced Dosing

Hope, W. W., Warn, P. A., Sharp, J., Reed, P., Keevil, B. G., Louie, A., Walsh, T. J., Denning, D. W., & Drusano, G. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00488-07 · Cited by 24 · see citing works

Granulocyte colony-stimulating factor-primed leukocyte transfusions in candida tropicalis fungemia in neutropenic patients.

Mario, A. D., Sica, S., Salutari, P., Barbera, E. O. L., Marra, R., & Leone, G. G. M. (1997) · PubMed · Cited by 23 · see citing works

Control of aCandida glabrataprosthetic endovascular infection with posaconazole

Anstead, G. M., Martinez, M., & Graybill, J. R. (2006) · Medical Mycology · doi:10.1080/13693780500049152 · Cited by 19 · see citing works

Successful intensive chemotherapy followed by autologous hematopoietic cell transplantation in a patient with acute myeloid leukemia and hepatosplenic candidiasis: case report and review of literature

Poon, L. M., Chia, H., Tan, L. ‐., Liu, T. ‐., & Koh, L. P. (2009) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2009.00363.x · Cited by 16 · see citing works

Caspofungin—a new therapeutic option for oropharyngeal candidiasis

Garbino, J. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1198-743x.2004.00823.x · Cited by 14 · see citing works

Caspofungin in the Treatment of Azole-Refractory Esophageal Candidiasis in Kidney Transplant Recipients

Veroux, M., Macarone, M., Fiamingo, P., Cappello, D., Gagliano, M., Mare, M. D., Vizcarra, D., Spataro, M., Giuffrida, G., Sorbello, M., et al. (2006) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.03.050 · Cited by 14 · see citing works

In Situ Liposomal Preparation Containing Amphotericin B: Related Toxicity and Tissue Disposition Studies

Chakraborty, K. K., & Suresh Ramnath, N. A. I. K. (2000) · Pharmaceutical Development and Technology · doi:10.1081/pdt-100102037 · Cited by 11 · see citing works

Early diagnosis and preemptive therapy of pulmonary mold infections in high-risk patients

Maertens, J. A., Huysmans, G., & Theunissen, K. (2008) · Current Infectious Disease Reports · doi:10.1007/s11908-008-0075-y · Cited by 9 · see citing works

Itraconazole IV solution in the treatment of candidemia in non-neutropenic patients

Tuil, O., & Cohen, Y. (2003) · Critical Care · doi:10.1186/cc2020 · Cited by 8 · see citing works

A reevaluation of nystatin in prophylaxis and treatment of oropharyngeal candidiasis.

Alvarez, M. E., Sánchez-Sousa, A., & Baquero, F. (1998) · PubMed · Cited by 7 · see citing works

The usefulness of the PlateliaCandidaantigen in a patient with acute lymphocytic leukemia and chronic disseminated candidiasis

Sun, H., Chiu, Y.-S., Tang, J., Wang, J., Chang, S., & Chen, Y. (2006) · Medical Mycology · doi:10.1080/13693780600735445 · Cited by 6 · see citing works

Infectious Complications from High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Metastatic Germ Cell Tumors

Jathavedam, A., Feldman, D. R., Ishill, N. M., Turkula, S., Patil, S., Bosl, G. J., Motzer, R. J., & Weinstock, D. M. (2008) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2008.02.020 · Cited by 5 · see citing works

ESCMID Diagnostic and management guideline for Candida diseases 2012: Developing European guidelines in clinical microbiology and infectious diseases.

Ullman, A. J., Cornely, O. A., Donnelly, P., et al. (2012) · Radboud Repository (Radboud University) · Cited by 5 · see citing works

Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.

Bárbaro, G., & Lorenzo, G. D. (1995) · PubMed · Cited by 5 · see citing works

Antifungal drugs: predicting clinical efficacy with pharmacodynamics

Nailor, M. D., & Chandrasekar, P. H. (2009) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.09.14 · Cited by 4 · see citing works

Invasive Candidiasis in the Neutropenic Cancer Patient

Gamaletsou, M. N., Sipsas, N. V., & Kontoyiannis, D. P. (2010) · Current Fungal Infection Reports · doi:10.1007/s12281-010-0044-4 · Cited by 4 · see citing works

Fluconazole in the Treatment of Mycotic Oropharyngeal Stomatitis and Esophagitis in Neutropenic Cancer Patients

Krcmery, V., Koza, I., Horníková, M., Fuchsberger, P., Spanik, S., Mardiak, J., Šufliarský, J., Blahová, M., Савко, В. В., & Migom, C. (2009) · Chemotherapy · doi:10.1159/000238877 · Cited by 3 · see citing works

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200 · see citing works

Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision

Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953 · see citing works

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

Ullmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556 · see citing works

ESCMID∗ guideline for the diagnosis and treatment of biofilm infections 2014

Høiby, N., Bjarnsholt, T., Moser, C. E., Bassi, G. L., Coenye, T., Donelli, G., Hall‐Stoodley, L., Holá, V., Imbert, C., Kirketerp‐Møller, K., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.10.024 · Cited by 801 · see citing works

Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology

Ashbee, H. R., Barnes, R. A., Johnson, E. M., Richardson, M. D., Gorton, R., & Hope, W. W. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt508 · Cited by 721 · see citing works

Changes in the epidemiological landscape of invasive candidiasis

Lamoth, F., Lockhart, S. R., Berkow, E. L., & Calandra, T. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx444 · Cited by 547 · see citing works

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections

Arendrup, M. C., Boekhout, T., Akova, M., Meis, J. F. G. M., Cornely, O. A., & Lortholary, O. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12360 · Cited by 533 · see citing works

Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM

Cornely, O. A., Sprute, R., Bassetti, M., Chen, W., Groll, A. H., Kurzai, O., Lass‐Flörl, C., Ostrosky‐Zeichner, L., Rautemaa‐Richardson, R., Revathi, G., et al. (2025) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00749-7 · Cited by 440 · see citing works

Mechanisms of <i>Candida</i> Biofilm Drug Resistance

Taff, H. T., Mitchell, K. F., Edward, J. A., & Andes, D. R. (2013) · Future Microbiology · doi:10.2217/fmb.13.101 · Cited by 422 · see citing works

Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines

Styczyński, J., van der Velden, W. J. F. M., Fox, C. P., Engelhard, D., de la Cámara, R., Cordonnier, C., Ljungman, P. T., & on behalf of the Sixth European Conference on Infections in Leukemia, A. J. V. O. T. I. D. W. P. O. T. E. S. O. B. A. M. T. (.-I. (2016) · Haematologica · doi:10.3324/haematol.2016.144428 · Cited by 411 · see citing works

Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients

Bellmann, R., & Smuszkiewicz, P. (2017) · Infection · doi:10.1007/s15010-017-1042-z · Cited by 399 · see citing works

Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004–2008

Pfaller, M. A., Andes, D. R., Diekema, D. J., Horn, D. L., Reboli, A. C., Rotstein, C., Franks, B., & Azie, N. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101510 · Cited by 396 · see citing works

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi

Chowdhary, A., Meis, J. F. G. M., Guarro, J., de Hoog, S., Kathuria, S., Arendrup, M. C., Arıkan-Akdağlı, S., Akova, M., Boekhout, T., Caira, M., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12515 · Cited by 381 · see citing works

Invasive candidiasis

Lass‐Flörl, C., Kanj, S. S., Govender, N. P., Thompson, G. R., Ostrosky-Zeichner, L. L., & Govrins, M. A. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00503-3 · Cited by 319 · see citing works

Candida Species Biofilms’ Antifungal Resistance

Silva, S. M., Rodrigues, C. F., Araújo, D., Rodrigues, M. E., & Henriques, M. (2017) · Journal of Fungi · doi:10.3390/jof3010008 · Cited by 308 · see citing works

Echinocandin resistance: an emerging clinical problem?

Arendrup, M. C., & Perlin, D. S. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000111 · Cited by 299 · see citing works

How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)

Arendrup, M. C., Friberg, N., Ma, M., Kahlmeter, G., Meletiadis, J., Guinea, J., Arendrup, M., Meletiadis, J., Guinea, J., Friberg, N., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.06.007 · Cited by 248 · see citing works

ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients

Maschmeyer, G., Helweg‐Larsen, J., Pagano, L., Robin, C., Cordonnier, C., & Schellongowski, P. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw158 · Cited by 231 · see citing works

Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia

Schmiedel, Y., & Zimmerli, S. (2016) · Swiss Medical Weekly · doi:10.4414/smw.2016.14281 · Cited by 226 · see citing works

Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme

Arendrup, M. C., Dzajic, E., Jensen, R. H., Johansen, H. K., Kjaldgaard, P., Knudsen, J. D., Kristensen, L., Leitz, C., Lemming, L. E., Nielsen, L., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12212 · Cited by 206 · see citing works

Invasive candidiasis: current clinical challenges and unmet needs in adult populations

Soriano, À., Honoré, P. M., Puerta‐Alcalde, P., García‐Vidal, C., Pagotto, A., Gonçalves, D. C., & Verweij, P. E. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad139 · Cited by 200 · see citing works

A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts

Bassetti, M., Marchetti, M., Chakrabarti, A., Colizza, S., Garnacho‐Montero, J., Kett, D. H., Muñóz, P., Cristini, F., Andoniadou, A., Viale, P., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-013-3109-3 · Cited by 198 · see citing works

Clinical hepatotoxicity associated with antifungal agents

Kyriakidis, I., Tragiannidis, A., Munchen, S., & Groll, A. H. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1270264 · Cited by 189 · see citing works

Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO)

Kochanek, M., Schalk, E., von Bergwelt‐Baildon, M., Beutel, G., Buchheidt, D., Hentrich, M., Henze, L., Kiehl, M. G., Liebregts, T., von Lilienfeld‐Toal, M., et al. (2019) · Annals of Hematology · doi:10.1007/s00277-019-03622-0 · Cited by 185 · see citing works

SUSCEPTIBILITY TEST FOR FUNGI: CLINICAL AND LABORATORIAL CORRELATIONS IN MEDICAL MYCOLOGY

Alastruey‐Izquierdo, A., Melhem, M. D. S. C., Bonfietti, L. X., & Rodriguez-Tudela, J. L. (2015) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652015000700011 · Cited by 184 · see citing works

Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer

Colombo, A. L., de Almeida, J. N., Slavin, M. A., Chen, S. C. ‐., & Sorrell, T. C. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30304-3 · Cited by 177 · see citing works

Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis

Jin, H., Wang, T., Falcione, B. A., Olsen, K. M., Chen, K., Tang, H., Hui, J., & Zhai, S. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw045 · Cited by 173 · see citing works

Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

Heinz, W., Buchheidt, D., Christopeit, M., von Lilienfeld‐Toal, M., Cornely, O. A., Einsele, H., Karthaus, M., Link, H., Mahlberg, R., Neumann, S., et al. (2017) · Annals of Hematology · doi:10.1007/s00277-017-3098-3 · Cited by 169 · see citing works

Invasive Fungal Infection

von Lilienfeld‐Toal, M., Wagener, J., Einsele, H., Cornely, O. A., & Kurzai, O. (2019) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2019.0271 · Cited by 165 · see citing works

Nosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis

Pfaller, M. A., & Castanheira, M. (2015) · Medical Mycology · doi:10.1093/mmy/myv076 · Cited by 161 · see citing works

Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors—Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)

Rieger, C. T., Liss, B., Mellinghoff, S. C., Buchheidt, D., Cornely, O. A., Egerer, G., Heinz, W., Hentrich, M., Maschmeyer, G., Mayer, K. T., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy117 · Cited by 152 · see citing works

Emergence of azole-resistantCandida parapsilosiscausing bloodstream infection: results from laboratory-based sentinel surveillance in South Africa

Govender, N. P., Patel, J., Magobo, R. E., Naicker, S. D., Wadula, J., Whitelaw, A. C., Coovadia, Y. M., Kularatne, R. S., Govind, C., Lockhart, S. R., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw091 · Cited by 145 · see citing works

Epidemiology and Outcome of Fungemia in a Cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031)

Cornely, O. A., Gachot, B., Akan, H., Bassetti, M., Uzun, Ö., Kibbler, C. C., Marchetti, O., de Burghgraeve, P., Ramadan, S., Pylkkänen, L., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ293 · Cited by 142 · see citing works

Critical care of patients with cancer

Shimabukuro‐Vornhagen, A., Böll, B., Kochanek, M., Azoulay, E., & von Bergwelt‐Baildon, M. S. (2016) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21351 · Cited by 134 · see citing works

Breakpoints for antifungal agents: An update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.

Arendrup, M. C., Cuenca-Estrella, M., Lass-Flörl, C., & Hope, W. W. (2013) · Drug Resistance Updates · doi:10.1016/j.drup.2014.01.001 · Cited by 129 · see citing works

Update from a 12-Year Nationwide Fungemia Surveillance: Increasing Intrinsic and Acquired Resistance Causes Concern

Astvad, K. M. T., Johansen, H. K., Røder, B. L., Rosenvinge, F. S., Knudsen, J. D., Lemming, L., Schønheyder, H. C., Hare, R. K., Kristensen, L., Nielsen, L., et al. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01564-17 · Cited by 125 · see citing works

Current status of antifungal resistance and its impact on clinical practice

Alcázar‐Fuoli, L., & Mellado, E. (2014) · British Journal of Haematology · doi:10.1111/bjh.12896 · Cited by 118 · see citing works

Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)

Cesaro, S., Ljungman, P. T., Mikulska, M., Hirsch, H. H., von Lilienfeld‐Toal, M., Cordonnier, C., Meylan, S., Mehra, V., Styczyński, J., Marchesi, F., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01578-1 · Cited by 118 · see citing works

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) and European Confederation of Medical Mycology (ECMM) 2013 joint guidelines on diagnosis and management of rare and emerging fungal diseases

Cornely, O. A., Cuenca‐Estrella, M., Meis, J. F. G. M., & Ullmann, A. J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12569 · Cited by 118 · see citing works

Safety and Pharmacokinetics of Isavuconazole as Antifungal Prophylaxis in Acute Myeloid Leukemia Patients with Neutropenia: Results of a Phase 2, Dose Escalation Study

Cornely, O. A., Böhme, A., Schmitt‐Hoffmann, A. H., & Ullmann, A. J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04569-14 · Cited by 115 · see citing works

Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry

Aslani, N., Janbabaei, G., Abastabar, M., Meis, J. F., Babaeian, M., Khodavaisy, S., Boekhout, T., & Badali, H. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-017-2916-5 · Cited by 114 · see citing works

Treatment of Invasive Candidiasis: A Narrative Review

Ben-Ami, R. (2018) · Journal of Fungi · doi:10.3390/jof4030097 · Cited by 111 · see citing works

Epidemiology of Invasive Candidiasis

Bays, D., Jenkins, E., Lyman, M., Chiller, T., Strong, N., Ostrosky-Zeichner, L., Hoenigl, M., Pappas, P., & Thompson, G. (2024) · Clinical Epidemiology · doi:10.2147/clep.s459600 · Cited by 109 · see citing works

Epidemiology, Management, and Outcome of Invasive Fungal Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation in China: A Multicenter Prospective Observational Study

Sun, Y., Meng, F., Han, M., Zhang, X., Yu, L., Huang, H., Wu, D., Ren, H., Wang, C., Shen, Z., et al. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.03.018 · Cited by 107 · see citing works

Prevention of Infections During Primary Immunodeficiency

Aguilar, C., Malphettes, M., Donadieu, J., Chandesris, M., Coignard-Biehler, H., Catherinot, É., Pellier, I., Stephan, J., Moing, V. L., Barlogis, V., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu646 · Cited by 105 · see citing works

Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, againstCandidaandAspergillusspp., including echinocandin- and azole-resistant isolates

Pfaller, M. A., Messer, S. A., Rhomberg, P. R., Jones, R. N., & Castanheira, M. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw214 · Cited by 103 · see citing works

Rapid Emergence of Echinocandin Resistance in Candida glabrata Resulting in Clinical and Microbiologic Failure

Lewis, J. S., Wiederhold, N. P., Wickes, B. L., Patterson, T. F., & Jorgensen, J. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01144-13 · Cited by 101 · see citing works

FEBRILE NEUTROPENIA IN ACUTE LEUKEMIA. EPIDEMIOLOGY, ETIOLOGY, PATHOPHYSIOLOGY AND TREATMENT

Hansen, B., Wendelbo, Ø., Bruserud, Ø., Hemsing, A. L., Mosevoll, K. A., & Reikvam, H. (2019) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2020.009 · Cited by 101 · see citing works

Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)

Penack, O., Becker, C., Buchheidt, D., Christopeit, M., Kiehl, M. G., von Lilienfeld‐Toal, M., Hentrich, M., Reinwald, M., Salwender, H. J., Schalk, E., et al. (2014) · Annals of Hematology · doi:10.1007/s00277-014-2086-0 · Cited by 100 · see citing works

Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology ( AGIHO )

Ruhnke, M., Behre, G., Buchheidt, D., Christopeit, M., Hamprecht, A. G., Heinz, W., Heußel, C. P., Horger, M., Kurzai, O., Karthaus, M., et al. (2018) · Mycoses · doi:10.1111/myc.12838 · Cited by 100 · see citing works

Recommendations from the 10th European Conference on Infections in Leukaemia for the management of cytomegalovirus in patients after allogeneic haematopoietic cell transplantation and other T-cell-engaging therapies

Ljungman, P. T., Alain, S., Chemaly, R. F., Einsele, H., Galaverna, F., Hirsch, H. H., Sadowska‐Klasa, A., Navarro, D., Styczyński, J., & de la Cámara, R. (2025) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(25)00069-6 · Cited by 99 · see citing works

Candidemia: Evolution of Drug Resistance and Novel Therapeutic Approaches

Tortorano, A. M., Prigitano, A., Morroni, G., Brescini, L., & Barchiesi, F. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s274872 · Cited by 96 · see citing works

Consensus statement for cancer patients requiring intensive care support

Kiehl, M. G., Beutel, G., Böll, B., Buchheidt, D., Forkert, R., Fuhrmann, V., Knöbl, P., Kochanek, M., Kroschinsky, F., Rosée, P. G. L., et al. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3312-y · Cited by 94 · see citing works

Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

Christopeit, M., Schmidt‐Hieber, M., Sprute, R., Buchheidt, D., Hentrich, M., Karthaus, M., Penack, O., Ruhnke, M., Weißinger, F., Cornely, O. A., et al. (2020) · Annals of Hematology · doi:10.1007/s00277-020-04297-8 · Cited by 89 · see citing works

Differential activity of the oral glucan synthase inhibitor SCY-078 against wild-type and echinocandin-resistant strains of Candida species

Pfaller, M. A., Messer, S. A., Rhomberg, P. R., Borroto-Esoda, K., & Castanheira, M. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00161-17 · Cited by 84 · see citing works

Clinical Pharmacokinetics and Pharmacodynamics of Micafungin

Wasmann, R. E., Muilwijk, E. W., Burger, D. M., Verweij, P. E., Knibbe, C. A. J., & Brüggemann, R. J. M. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0578-5 · Cited by 84 · see citing works

Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain

Puig‐Asensio, M., Ruíz-Camps, I., Fernández‐Ruiz, M., Aguado, J. M., Muñóz, P., Valerio, M., Delgado‐Iribarren, A., Merino, P., Bereciartúa, E., Fortün, J., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.12.027 · Cited by 79 · see citing works

Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7‐year study

Tadec, L., Talarmin, J., Gastinne, T., Bretonnière, C., Miegeville, M., Pape, P. L., & Morio, F. (2016) · Mycoses · doi:10.1111/myc.12470 · Cited by 79 · see citing works

Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China

Sun, Y., Huang, H., Chen, J., Li, J., Ma, J., Li, J., Liang, Y., Wang, J., Li, Y., Kang, Y., et al. (2014) · Tumor Biology · doi:10.1007/s13277-014-2649-7 · Cited by 78 · see citing works

Treatment of invasive fungal diseases in cancer patients—Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

Ruhnke, M., Cornely, O. A., Schmidt‐Hieber, M., Alakel, N., Boell, B., Buchheidt, D., Christopeit, M., Hasenkamp, J., Heinz, W., Hentrich, M., et al. (2020) · Mycoses · doi:10.1111/myc.13082 · Cited by 76 · see citing works

Improving outcome of fungal diseases – Guiding experts and patients towards excellence

Cornely, O. A., Lass‐Flörl, C., Lagrou, K., Arsić-Arsenijević, V. S., & Hoenigl, M. (2017) · Mycoses · doi:10.1111/myc.12628 · Cited by 75 · see citing works

Use of Micafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 3,764 Clinical Isolates of Candida by Use of CLSI Methods and Interpretive Criteria

Pfaller, M. A., Messer, S. A., Diekema, D. J., Jones, R. N., & Castanheira, M. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02481-13 · Cited by 74 · see citing works

Antifungal Susceptibility Profiles of Bloodstream Yeast Isolates by Sensititre YeastOne over Nine Years at a Large Italian Teaching Hospital

Posteraro, B., Spanu, T., Fiori, B., Maio, F. D., Carolis, E. D., Giaquinto, A., Prete, V., Angelis, G. D., Torelli, R., D’Inzeo, T., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00285-15 · Cited by 74 · see citing works

Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus

Henze, L., Buhl, C., Sandherr, M., Cornely, O. A., Heinz, W., Khodamoradi, Y., Kiderlen, T. R., Koehler, P. A., Seidler, A., Sprute, R., et al. (2022) · Annals of Hematology · doi:10.1007/s00277-021-04746-y · Cited by 72 · see citing works

Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL)

Pagano, L., Maschmeyer, G., Lamoth, F., Blennow, O., Xhaard, A., Spadea, M., Busca, A., Cordonnier, C., Maertens, J. A., On behalf of, E. C. I. L., et al. (2025) · Leukemia · doi:10.1038/s41375-025-02586-7 · Cited by 71 · see citing works

Epidemiology, species distribution and outcome of nosocomial Candida spp.bloodstream infection in Shanghai

Yang, Z., Wu, L., Liu, X., Zhou, M., Li, J., Wu, J., Cai, Y., Mao, E., Chen, E., & Lortholary, O. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-241 · Cited by 70 · see citing works

Rapid Development of Candida krusei Echinocandin Resistance during Caspofungin Therapy

Forastiero, A., Garcia-Gil, V., Rivero-Menéndez, O., Garcia‐Rubio, R., Monteiro, M. C., Alastruey‐Izquierdo, A., Jordán, R., Agorio, I., & Mellado, E. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01005-15 · Cited by 68 · see citing works

Role and Interpretation of Antifungal Susceptibility Testing for the Management of Invasive Fungal Infections

Lamoth, F., Lewis, R. E., & Kontoyiannis, D. P. (2020) · Journal of Fungi · doi:10.3390/jof7010017 · Cited by 68 · see citing works

Positions and Numbers of <i>FKS</i> Mutations in Candida albicans Selectively Influence <i>In Vitro</i> and <i>In Vivo</i> Susceptibilities to Echinocandin Treatment

Lackner, M., Tscherner, M., Schaller, M., Kuchler, K., Mair, C., Sartori, B., Istel, F., Arendrup, M. C., & Lass-Flörl, C. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00123-14 · Cited by 67 · see citing works

Caspofungin: Pharmacodynamics, pharmacokinetics, clinical uses and treatment outcomes

Song, J., & Stevens, D. A. (2015) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2015.1068271 · Cited by 62 · see citing works

Systemic Antifungal Agents: Current Status and Projected Future Developments

Seyedmousavi, S., Rafati, H., İlkit, M., Tolooe, A., Hedayati, M. T., & Verweij, P. E. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6515-1_5 · Cited by 61 · see citing works

Progress in Definition, Prevention and Treatment of Fungal Infections in Cystic Fibrosis

Schwarz, C., Hartl, D., Eickmeier, O., Hector, A., Benden, C., Durieu, I., Solé, A., Gärtner, S., Milla, C. E., & Barry, P. J. (2017) · Mycopathologia · doi:10.1007/s11046-017-0182-0 · Cited by 61 · see citing works

Efficacy and safety of amphotericin B formulations: a network meta-analysis and a multicriteria decision analysis

Tonin, F. S., Steimbach, L. M., Borba, H. H. L., Sanches, A. C. C., Wiens, A., Pontarolo, R., & Fernández-Llimós, F. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12802 · Cited by 61 · see citing works

Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002–14)

Bretagne, S., Renaudat, C., Desnos‐Ollivier, M., Sitbon, K., Lortholary, O., Dromer, F., & on behalf of the French Mycosis Study Group (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx045 · Cited by 60 · see citing works

What are the 100 most cited fungal genera?

Bhunjun, C. S., Chen, Y. J., Phukhamsakda, C., Boekhout, T., Groenewald, J. Z., McKenzi, E. H. C., Francisco, E. C., Frisvad, J. C., Groenewald, M., Hurdeal, V. G., et al. (2024) · Studies in Mycology · doi:10.3114/sim.2024.108.01 · Cited by 57 · see citing works

Susceptibility testing of fungi to antifungal drugs

Sanguinetti, M., & Posteraro, B. (2018) · Journal of Fungi · doi:10.3390/jof4030110 · Cited by 55 · see citing works

Use of Anidulafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 4,290 Clinical Isolates of Candida by Using CLSI Methods and Interpretive Criteria

Pfaller, M. A., Diekema, D. J., Jones, R. N., & Castanheira, M. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00782-14 · Cited by 51 · see citing works

Multicenter Study of Anidulafungin and Micafungin MIC Distributions and Epidemiological Cutoff Values for Eight Candida Species and the CLSI M27-A3 Broth Microdilution Method

Pfaller, M. A., Espinel‐Ingroff, A., Bustamante, B., Cantón, R., Diekema, D. J., Fothergill, A., Fuller, J., González, G. M., Guarro, J., Lass‐Flörl, C., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02020-13 · Cited by 51 · see citing works

Breakthrough candidaemia in the era of broad-spectrum antifungal therapies

Cuervo, G., Garcia-Vidal, C., Nucci, M., Puchades, F., Fernández-Ruiz, M., Obed, M., Manzur, A., Gudiol, C., Pemán, J., Aguado, J. M., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.09.029 · Cited by 49 · see citing works

New developments and directions in the clinical application of the echinocandins

Chang, C. C., Slavin, M. A., & Chen, S. C. A. (2017) · Archives of Toxicology · doi:10.1007/s00204-016-1916-3 · Cited by 49 · see citing works

2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy

Giesen, N., Sprute, R., Rüthrich, M. M., Khodamoradi, Y., Mellinghoff, S. C., Beutel, G., Lueck, C., Koldehoff, M., Hentrich, M., Sandherr, M., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.01.033 · Cited by 47 · see citing works

Effects of antifungal stewardship using therapeutic drug monitoring in voriconazole therapy on the prevention and control of hepatotoxicity and visual symptoms: A multicentre study conducted in Japan

Hamada, Y., Ueda, T., Miyazaki, Y., Nakajima, K., Fukunaga, K., Miyazaki, T., Nakada, N., Nagao, M., Kawamura, H., Shigemi, A., et al. (2020) · Mycoses · doi:10.1111/myc.13129 · Cited by 47 · see citing works

Up to date epidemiology, diagnosis and management of invasive fungal infections

Oren, I., & Paul, M. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12642 · Cited by 46 · see citing works

Isavuconazole and Nine Comparator Antifungal Susceptibility Profiles for Common and Uncommon Candida Species Collected in 2012: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values

Castanheira, M., Messer, S. A., Rhomberg, P. R., Dietrich, R. D., Jones, R. N., & Pfaller, M. A. (2014) · Mycopathologia · doi:10.1007/s11046-014-9772-2 · Cited by 46 · see citing works

Old and new pathogenicNakaseomycesspecies: epidemiology, biology, identification, pathogenicity and antifungal resistance

Angoulvant, A., Guitard, J., & Hennequin, C. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov114 · Cited by 45 · see citing works

Outbreaks of Fungal Infections in Hospitals: Epidemiology, Detection, and Management

Douglas, A. P., Stewart, A. G., Halliday, C. L., & Chen, S. C. ‐. (2023) · Journal of Fungi · doi:10.3390/jof9111059 · Cited by 44 · see citing works

<scp>EUCAST</scp> Technical Note on <i>Candida</i> and micafungin, anidulafungin and fluconazole

Cavling Arendrup, M., Cuenca‐Estrella, M., Lass‐Flörl, C., Hope, W. W., & The European Committee on Antimicrobial Susceptibility Testing – Subcommittee on Antifungal Susceptibility Testing (EUCAST‐AFST) (2014) · Mycoses · doi:10.1111/myc.12170 · Cited by 43 · see citing works

Impact of special patient populations on the pharmacokinetics of echinocandins

Muilwijk, E. W., Lempers, V. J. C., Burger, D. M., Warris, A., Pickkers, P., Aarnoutse, R. E., & Brüggemann, R. J. M. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1028366 · Cited by 43 · see citing works

Emerging Candida species isolated from renal transplant recipients: Species distribution and susceptibility profiles

Diba, K., Makhdoomi, K., Nasri, E., Vaezi, A., Javidnia, J., Gharabag, D. J., Jazani, N. H., Chavshin, A. R., Badiee, P., Badali, H., et al. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.09.026 · Cited by 43 · see citing works

Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: critical appraisal

Leroux, S., & Ullmann, A. J. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12426 · Cited by 42 · see citing works

Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus

Mirabile, A., Numico, G., Russi, E. G., Bossi, P., Crippa, F., Bacigalupo, A., Sanctis, V. D., Musso, S., Merlotti, A. M., Ghi, M. G., et al. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.03.003 · Cited by 42 · see citing works

Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects

Akan, H., Antia, V., Kouba, M., Sinkó, J., Tanase, A. D., Vrḫovac, R., & Herbrecht, R. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt389 · Cited by 42 · see citing works

Performance of two MALDI-TOF MS systems for the identification of yeasts isolated from bloodstream infections and cerebrospinal fluids using a time-saving direct transfer protocol

Hamprecht, A. G., Christ, S., Oestreicher, T., Plum, G., Kempf, V. A. J., & Göttig, S. (2013) · Medical Microbiology and Immunology · doi:10.1007/s00430-013-0319-9 · Cited by 41 · see citing works

Echinocandin Resistance in Candida Species: a Review of Recent Developments

Wiederhold, N. P. (2016) · Current Infectious Disease Reports · doi:10.1007/s11908-016-0549-2 · Cited by 41 · see citing works

Emergence of resistantCandida glabratain Germany

Aldejohann, A. M., Herz, M., Martin, R., Walther, G., & Kurzai, O. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab122 · Cited by 41 · see citing works

Incidence, Risk Factors, and Long-term Outcome of Acute Leukemia Patients With Early Candidemia After Allogeneic Stem Cell Transplantation: A Study by the Acute Leukemia and Infectious Diseases Working Parties of European Society for Blood and Marrow Transplantation

Cesaro, S., Tridello, G., Blijlevens, N. M. A., Ljungman, P. T., Craddock, C., Michallet, M., Martin, A. M., Snowden, J. A., Mohty, M., Maertens, J. A., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy150 · Cited by 40 · see citing works

Hepatosplenic candidiasis

Cornely, O. A., Bangard, C., & Jaspers, N. (2015) · Clinical Liver Disease · doi:10.1002/cld.491 · Cited by 39 · see citing works

Micafungin

Scott, L. J. (2012) · Drugs · doi:10.2165/11209970-000000000-00000 · Cited by 39 · see citing works

Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)

Giesen, N., Sprute, R., Rüthrich, M. M., Khodamoradi, Y., Mellinghoff, S. C., Beutel, G., Lueck, C., Koldehoff, M., Hentrich, M., Sandherr, M., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.09.009 · Cited by 38 · see citing works

Micafungin breakthrough fungemia in patients with hematological disorders

Kimura, M., Araoka, H., Yamamoto, H., Nakamura, S., Nagi, M., Yamagoe, S., Miyazaki, Y., Ogura, S., Mitsuki, T., Yuasa, M., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02183-17 · Cited by 37 · see citing works

P971 Amphotericin B does not affect the pharmacokinetics of micafungin (FK463)

Undre, N. A., Stevenson, P., & Wilbraham, D. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(07)70812-9

Management of invasive mycoses in hematology patients: current approaches.

Perfect, J. R. (2004) · PubMed · Cited by 13 · see citing works

Candidaemia in Patients with Haematological Disorders and Stem Cell Transplant

Al‐Anazi, K. A., & Al-Jasser, A. M. (2006) · Libyan Journal of Medicine · doi:10.3402/ljm.v1i2.4673 · Cited by 5 · see citing works

Candidemia in Cancer Patients: Focus Mainly on Hematological Malignancyand Hematopoietic Stem Cell Transplantation

Okinaka, K. (2016) · Medical Mycology Journal · doi:10.3314/mmj.16.003 · Cited by 4 · see citing works

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

Tissot, F., Agrawal, S., Pagano, L., Petrikkos, G., Groll, A. H., Skiada, A., Lass-Flörl, C., Calandra, T., Viscoli, C., & Herbrecht, R. (2017) · Haematologica · doi:10.3324/haematol.2016.152900 · Cited by 682 · see citing works